HYPR (Hyperfine) NonCurrent Deferred Liabilities: $0.71 Mil (As of Mar. 2026)


HYPR Hyperfine Inc HYPR
80 GF Score
Price $1.09
GF Value $1.33
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hyperfine NonCurrent Deferred Liabilities?

Hyperfine HYPR -1.36% 80 NonCurrent Deferred Liabilities is $0.71 Mil as of Mar. 2026. GuruFocus rates HYPR with a GF Score™ of 80/100 and a GF Value™ of $1.33 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Hyperfine's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $0.71 Mil.

Hyperfine NonCurrent Deferred Liabilities Related Terms

Hyperfine NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Hyperfine's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyperfine NonCurrent Deferred Liabilities Chart

Hyperfine Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.51 1.53 0.97 1.05 0.73

Hyperfine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 0.91 0.97 0.73 0.71
HYPR
80GF Score
Hyperfine Inc HYPR
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $0.71 Mil mean?
Hyperfine (HYPR) has a NonCurrent Deferred Liabilities of $0.71 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Hyperfine and its competitors.
Is Hyperfine's NonCurrent Deferred Liabilities too high?
Hyperfine's current NonCurrent Deferred Liabilities is $0.71 Mil. Overall, Hyperfine has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hyperfine's NonCurrent Deferred Liabilities compare to CVRX and MXCT?
Hyperfine's NonCurrent Deferred Liabilities of $0.71 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Hyperfine and its competitors. Hyperfine's current NonCurrent Deferred Liabilities is $0.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyperfine stock overvalued right now?
Based on GuruFocus' analysis, Hyperfine (HYPR) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.33, compared to a current price of $1.09 — trading 18.4% below its estimated fair value. The current NonCurrent Deferred Liabilities is $0.71 Mil. Hyperfine's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Hyperfine (HYPR), the current NonCurrent Deferred Liabilities is $0.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hyperfine (HYPR) Overvalued in 2026?

Based on GuruFocus' analysis, Hyperfine stock appears to be undervalued. The current stock price of $1.09 is trading 18.4% below its estimated GF Value™ of $1.33. GuruFocus considers Hyperfine to be Modestly Undervalued.

Key valuation signals for HYPR:

  • NonCurrent Deferred Liabilities: $0.71 Mil
  • GF Value™: $1.33 vs. price of $1.09 (18.4% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the HYPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hyperfine Business Description

Address 351 New Whitfield Street, Guilford, CT, USA, 06437
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
80GF Score

Get the complete analysis for HYPR

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.09
Price
$1.33
GF Value